Drug
Amoxicillin and clavulanic acid
Amoxicillin and clavulanic acid is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph phase_1
1
25%
Ph phase_4
3
75%
Phase Distribution
1
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 4Post-market surveillance
3(75.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 43 (75.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_1
Pharmacokinetic Study of the Association of Amoxicillin / Clavulanic Acid to Obese Adults
NCT02571959
completedphase_4
Effectiveness of Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease
NCT00495586
completedphase_4
Non Operative Treatment for Acute Appendicitis
NCT01096927
completedphase_4
Antibiotic Therapy is Not Necessary to Implant Totally Implantable Venous Access Devices: Randomized Prospective Study
NCT00665873
Clinical Trials (4)
Showing 4 of 4 trials
NCT02571959Phase 1
Pharmacokinetic Study of the Association of Amoxicillin / Clavulanic Acid to Obese Adults
NCT00495586Phase 4
Effectiveness of Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease
NCT01096927Phase 4
Non Operative Treatment for Acute Appendicitis
NCT00665873Phase 4
Antibiotic Therapy is Not Necessary to Implant Totally Implantable Venous Access Devices: Randomized Prospective Study
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4